DNA Damage-Inducing Anticancer Drugs (N/A)

DNA damage-inducing anticancer drugs are a diverse class of therapeutic agents that target DNA structure, replication, and repair mechanisms. They induce DNA damage in rapidly dividing cancer cells, leading to cell death. These drugs operate through mechanisms such as topoisomerase inhibition, alkylation, platinum adduct formation, and oxidative stress induction. Resistance can develop through enhanced repair capabilities or redox system upregulation. Safety concerns include secondary malignancies and organ toxicities.

Other names

DNA damaging agentsGenotoxic agentsDNA-targeting anticancer drugs

Various mechanisms including topoisomerase inhibition, DNA alkylation, platinum adduct formation, and oxidative stress induction, leading to DNA damage and cell death.